Hepatic NMNAT1 Is Required to Defend against Alcohol-Associated Fatty Liver Disease

Decreased nicotinamide mononucleotide adenylyltransferase 1 (NMNAT1) expression and activity were observed in the liver of patients with alcohol-associated hepatitis and either liver or primary hepatocytes from alcohol-associated liver disease mice.